cronos group glp-1 receptor agonist weight management diabetes treatments Targeting GLP-1, GIP & GCG in Obesity and Type 2 Research cronos group glp-1 receptor agonist

Tumor cells with BRCA1/2 mutations can be targeted using poly ADP ribose polymerase (PARP) inhibitors like olaparib and talazoparib ( TP53 (associated with Li-Fraumeni syndrome) and PTEN (linked to Cowden syndrome) have been found to be associated with familial breast cancer, as these genes are heritable, keeping women at potential risk to develop cancer during their lifetime ( PALB2, ATM , and CHEK2 ( The polygenic nature of breast cancer has been illuminated by the polygenic risk score computed based on multiple genome-wide association studies (GWAS), implicating over 180 single-nucleotide polymorphisms ( BRCA1, BRCA2, TP53, CDH1, ATM, PALB2, STK11 , and more, offering comprehensive genetic risk assessments ( Genetic risk factors and molecular subtypes together influence treatment outcomes

Gabby M, Tauber M, Porat S, Simantov R

Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats Exp Gerontol 1994

[75] Liu AG, Juvik JA, Jeffery EH, et al

Metabolic phenotype: these factors correlate with observable metabolic characteristics